A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer - Concepedia

Concepedia

Publication | Open Access

A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer

DOI Full Paper Access

115

Citations

23

References

2006

Year

Athanassios Argiris, Ezra E.W. Cohen, Theodore Karrison, Benjamin Esparaz, Ann M. Mauer, Rafat Ansari, Stuart J. Wong, Yi Fang Lu, Michael Pins, Janet Dancey,

Cancer Biology & Therapy

Abstract

Perifosine in the doses and schedule used lacks single-agent activity in SCCHN. Our data do not justify further investigation of perifosine as a single agent in SCCHN.

References

	Year	Citations

Page 1